Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays

Nature Medicine

Volumn 2, Issue 7, 1996, Pages 753-759

  Kozal, Michael J ^a,e   Shah, Nila ^a   Shen, Naiping ^a   Yang, Robert ^a   Fucini, Raymond ^a   Merigan, Thomas C ^b   Richman, Douglas D ^c,d   Morris, Don ^a   Hubbell, Earl ^a   Chee, Mark ^a   Gingeras, Thomas R ^a  

^a Thermo Fisher Scientific   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; DNA POLYMORPHISM; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

AMINO ACID SEQUENCE; BASE SEQUENCE; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; POLYMORPHISM, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 15844378825     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0796-753     Document Type: Article

References (28)

1. Kohl, N.E. et al. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85, 4686-4690 (1988).
2. LeGrice, S.F., Mills, J. & Mous, J. Active site mutations of AIDS virus protease and its alleviation by trans complementation. EMBO J. 7, 2547-2553 (1988).
3. Peng, C., Ho, B.K., Chang, T.W. & Chang, N.T. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J. Virol. 63, 2550-2556 (1989).
4. Meyers, G. et al. (eds.) Human Retrovirises and AIDS, vol. I, 79-83; vol. III, 97-106 (Los Alamos National Laboratory, New Mexico, 1994).
5. Meyers, G. et al. (eds.) Human Retrovirises and AIDS, vol. I, 79-83; vol. III, 97-106 (Los Alamos National Laboratory, New Mexico, 1994).
6. Miller, M., Jaskólski, M., Mohana Rao, J.K., Leis, J. & Wlodawer, A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337, 576-578 (1989).
7. Toh, H., Ono, M., Saigo, K. & Miyata, T. Retroviral protease-like sequence in yeast transposon Ty1. Nature 315, 691 (1985).
8. Pillay, D., Bryant, M., Getman, D. & Richman, D.D. HIV-1 protease inhibitors: Their development, mechanism of action and clinical potential. Rev. Med. Virol. 5, 23-33 (1995).
9. Mellors, J.W., Larder, B.A. & Schinazi, R.F. Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antiviral News 3, 8-13 (1995).
10. Condra, J.H. et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569-571 (1995).
11. Fodor, S.P. et al. Light-directed, spatially addressable parallel chemical synthesis. Science 251, 767-773 (1991).
12. Pease, A.C. et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc. Natl. Acad. Sci. USA 91, 5022-5026 (1994).
13. Lipshutz, R.J. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19, 442-447 (1995).
14. Lipshutz, R.J. & Fodor, S.P.A. Advanced DNA sequencing technologies. Curr. Opin. Struct. Biol. 4, 376-380 (1994).
15. Rose, B. et al. in HIV Drug-Resistance Third International Workshop, p. 17, 2-5 August 1994, Kauai, Hawaii (1994).
16. Kaplan, A.H. et al. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc. Natl. Acad. Sci. USA 91, 5022-5026 (1994).
17. Tisdale, M. in HIV Drug-Resistance Third International Workshop, p. 14, 2-5 August 1994, Kauai, Hawaii (1994).
18. Sanchez-Pescador, R. et al. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227, 484-492 (1985).
19. Theodore, T. & Buckler-White, A. in Human Retroviruses and AIDS (eds. Myers, G. et al.) 162-165 (Los Alamos National Laboratory, New Mexico, 1990).
20. Ratner, L. et al. Complete nucleotide sequence of the AIDS virus, HTL-VIII. Nature 313, 277-284 (1985).
21. Gingeras, T.R. et al. Use of self-sustained sequence replication (3SR) amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus. J. Infect. Dis. 164, 1066-1074 (1991).
22. Delwart, E.L. et al. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 262, 1257-1261 (1993).
23. Coffin, J.M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489 (1995).
24. Ho, D.D. et al. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J. Virol. 68, 2016-2020 (1994).
25. Eckert, K.A. & Kunkel, T.A. DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl. 1, 17-24 (1991).
26. Tabor, S. & Richardson, C.C. A single hydroxyl moiety in a pol I-type DNA polymerase is responsible for distinguishing between deoxy- and dideoxynucleotides. Proc. Natl. Acad. Sci. USA 92, 6639-6643 (1995).
27. Potts, K.E. et al. in HIV Drug-Resistance Third International Workshop, p. 4, 2-5 August 1994, Kauai, Hawaii (1994).
28. Jacobsen, H. et al. in HIV Drug-Resistance Third International Workshop, p. 16, 2-5 August 1994, Kauai, Hawaii (1994).